Related Experiment Video
Updated: Mar 16, 2026

08:25
Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
1.3K
STRESS IN PEDIATRIC PATIENTS--THE EFFECT OF PROLONGED HOSPITALIZATION.
Summary
Long-term hospitalization causes significant emotional distress in children, impacting their development. Current methods cannot precisely measure this stress, highlighting the need for better evaluation tools.
Area of Science:
- Pediatric Medicine
- Psychoneuroendocrinology
- Child Psychology
Background:
- Long-term hospitalization profoundly impacts children emotionally due to isolation from family and familiar environments.
- Stressful situations elicit complex physiological responses, but current laboratory markers cannot quantify stress intensity.
- The hospital environment and illness act as significant stressors for pediatric patients and their caregivers.
Purpose of the Study:
- To explore the emotional and physiological impact of long-term hospitalization on children.
- To review current methods for evaluating stress response in hospitalized children.
- To emphasize the importance of minimizing hospitalization duration and involving family physicians.
Main Methods:
- Review of neuroendocrine, immunological, and metabolic markers of stress response.
- Discussion of the hypothalamic-pituitary-adrenal (HPA) axis activation during stress.
- Analysis of the psychological effects of hospitalization on child development.
Main Results:
- The neuroendocrine system, particularly the hypothalamic-pituitary-adrenal axis, is a primary responder to stress.
- Chronic stress can lead to cortisol synthesis and potential hypo-secretion of other adrenal steroids.
- Hospitalization disrupts a child's normal life, affecting development and potentially leading to long-term issues.
Conclusions:
- Effective stress quantification in pediatric patients remains a challenge due to complex physiological mechanisms.
- Early intervention by family doctors can prevent unnecessary hospitalizations.
- Minimizing the duration of pediatric hospital stays is crucial to mitigate negative impacts on child well-being and development.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
419
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Pharmacokinetics in Pediatric Patients: Drug Excretion
354
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
641
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Pharmacokinetics in Pediatric Patients: Drug Metabolism
312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pneumonia I: Introduction
1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia IV: Management
1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
